Precision Antibody

Precision Antibody, a leader in custom monoclonal antibody development, is pleased to announce its participation in the 20th Drug Discovery Strategic Summit (DDSS Europe), taking place November 19–20, 2025, in Amsterdam, Netherlands.

Precision Antibody will showcase its biomarker antibody expertise at the World ADC Conference 2025 in San Diego, highlighting its role in advancing ADC and cancer biomarker research through high-quality monoclonal antibody development.

Columbia, MD—Precision Antibody, a leading provider of custom monoclonal antibody development services, is pleased to announce its participation in the Antibody Engineering & Therapeutics Asia 2025, taking place October 20–22 at The Westin Miyako...

Columbia, MD—Precision Antibody, a recognized leader in custom monoclonal antibody development, is pleased to announce its participation in the 19th Drug Discovery Strategic Summit (DDSS), taking place October 15–16, 2025, in San Francisco,...

Columbia, MD—Precision Antibody, a leader in custom monoclonal antibody development, is pleased to announce its participation in the upcoming World Clinical Biomarkers & CDx Summit (World CDx), taking place September 23–25, 2025, in Boston,...

Columbia, MD—Precision Antibody, a leading biotechnology company specializing in the development of custom monoclonal antibodies, is excited to announce its participation in Interphex Regenerative Medicine 2025, taking place July 9–11, 2025, at Tokyo...

Precision Antibody, a leading provider of custom monoclonal antibody development services, is pleased to announce its attendance at the upcoming Antibody Engineering & Therapeutics Europe, taking place June 10–12, 2025, at the Congress Center...

Columbia, MD—The founder, Dr. Jun Hayashi, and the CEO, Dr. Ginette Serrero, of Precision Antibody, a leading service provider for custom monoclonal antibody development, will be the chief speakers at "Drug Discovery Strategic Summit (DDSS) 2025" that...